Michael S Wyzga Logic Bio Therapeutics, Inc. (LOGC) insider trading activity

LOGC Quotes by TradingView

Michael S Wyzga is Director of LogicBio Therapeutics, Inc.. Currently has a direct ownership of 0 shares of LOGC, which is worth approximately $0. The most recent transaction as insider was on Nov 16, 2022, when has been sold 3,141 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MICHAEL S WYZGA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2022
SELL
Sale (or disposition) back to the issuer
-
3,141 Reduced 100.0%
0 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
3,141 Added 50.0%
3,141 Common Stock

Also insider at

EXAS
EXACT SCIENCES CORP Healthcare
Director
XFOR
X4 Pharmaceuticals, Inc Healthcare
Director
ADGI
Adagio Therapeutics, Inc. Healthcare
Director
MREO
Mereo Biopharma Group plc Healthcare
MSW

Michael S Wyzga

Director
Madison, WI

Track Institutional and Insider Activities on LOGC

Follow LogicBio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LOGC shares.

Notify only if

Insider Trading

Get notified when an Logic Bio Therapeutics, Inc. insider buys or sells LOGC shares.

Notify only if

News

Receive news related to LogicBio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LOGC